Skip to content
10-K

Annual Report

Treace Medical Concepts, Inc. TMCI

0000950170-25-029029

← back to feed
Filed
Feb 27, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 19, 2025 62.62M sh
Long Term Debt FY 2024 · Dec 31, 2023 $53.01M
Cash And Equivalents FY 2024 · Dec 31, 2023 $12.98M
Current Liabilities FY 2024 · Dec 31, 2023 $45.03M
Total Liabilities FY 2024 · Dec 31, 2023 $113.97M
Current Assets FY 2024 · Dec 31, 2023 $198.36M
Total Assets FY 2024 · Dec 31, 2023 $251.91M
Shares Diluted FY 2024 · Dec 31, 2022 55.28M sh
Capex FY 2024 · Dec 31, 2022 $14.84M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$30.65M
Eps Diluted FY 2024 · Dec 31, 2022 −$0.77
Eps Basic FY 2024 · Dec 31, 2022 −$0.77
Sga Expense FY 2024 · Dec 31, 2022 $33M
Rd Expense FY 2024 · Dec 31, 2022 $13.58M
Net Income FY 2024 · Dec 31, 2022 −$42.82M
Operating Income FY 2024 · Dec 31, 2022 −$34.84M
Gross Profit restated FY 2024 · Dec 31, 2022 $116.31M
Cost Of Revenue restated FY 2024 · Dec 31, 2022 $25.53M
Revenue FY 2024 · Dec 31, 2022 $141.84M
Stockholders Equity FY 2024 · Dec 31, 2021 $93.07M